Hartman et al., 1999 - Google Patents
MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancerHartman et al., 1999
View PDF- Document ID
- 374265144290696603
- Author
- Hartman M
- Baruch A
- Ron I
- Aderet Y
- Yoeli M
- Sagi‐Assif O
- Greenstein S
- Stadler Y
- Weiss M
- Harness E
- Yaakubovits M
- Keydar I
- Smorodinsky N
- Wreschner D
- Publication year
- Publication venue
- International journal of cancer
External Links
Snippet
The products of the MUC1 gene are known to be highly expressed in human breast cancer cells. The best characterized MUC1 protein is a polymorphic, type 1 transmembrane molecule containing a large extracellular domain composed primarily of a variable number …
- 102100006037 MUC1 0 title abstract description 298
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hartman et al. | MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer | |
| JP3859695B2 (en) | C-erbB-2 foreign domain: GP75 | |
| Baruch et al. | The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein | |
| EP0636029B1 (en) | Antibodies specific for carcinoma-associated antigens | |
| US20200325215A1 (en) | COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a | |
| EP0344134B1 (en) | Monoclonal antibody specific to a fibronectin sequence expressed in transformed cells, hybridoma secreting said antibody and use of said monoclonal antibody in the diagnosis of tumors | |
| NZ590225A (en) | Genetic products differentially expressed in tumors and the use thereof | |
| CA2563666C (en) | Differentially expressed claudin-18 variants in tumors and use thereof | |
| US20080248507A1 (en) | C-erbB-2 external domain: GP75 | |
| Hernaez et al. | PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin | |
| JPH08506801A (en) | Peptides corresponding to CD44 exon 6, antibodies specific to the peptides, and methods of using these antibodies for tumor diagnosis | |
| KR101374758B1 (en) | A marker comprising anti-CK8/18 complex autoantibodies and a composition comprising antigen thereof for diagnosing cancer | |
| US20080241066A1 (en) | Anti-PRL-3 antibodies and methods of use thereof | |
| Okada et al. | Anti-(glioma surface antigen) monoclonal antibody G-22 recognizes overexpressed CD44 in glioma cells | |
| AU2016203425C1 (en) | Genetic products differentially expressed in tumors and the use thereof | |
| Strelkauskas et al. | The Use of Human Monoclonal Antibodies to Identify and Isolate Breast Tumor Associated Antigens | |
| AU2011256897B2 (en) | Genetic products differentially expressed in tumors and the use thereof | |
| JP2005154389A (en) | Antibodies that identify the form of CD44 | |
| HK1029800A (en) | C-erbb-2 external domain: gp75 | |
| HK1191056B (en) | Compositions and methods of use for determination of he4a |